Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1205
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 26, 2018
Authors
Publisher
Wiley